Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-002691
Filing Date
2025-01-10
Accepted
2025-01-10 20:01:44
Documents
1
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252892-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm252892-5_4seq1.xml 4 4203
  Complete submission text file 0001104659-25-002691.txt   5646
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Yocca Frank (Reporting) CIK: 0001733272 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 25524431